Rising illegal drug use & injection of drugs since 1990s
|
|
- Aron Douglas
- 6 years ago
- Views:
Transcription
1 Characterizing the overdose risk environment in St. Petersburg, Russia Traci C. Green, Lauretta E. Grau, Ksenia Blinnikova, Mikhail Torban, Evgeny Krupitsky, Ruslan Ilyuk, Andrei Kozlov, Robert Heimer Yale School of Public Health Center for Interdisciplinary i Research on AIDS New Haven, Connecticut Bekhterev State Research Psychoneurological Institute The Biomedical Center St. Petersburg, Russia
2 A Russian overdose epidemic Rising illegal drug use & injection of drugs since 1990s >5% of adults in some cities inject drugs Increasing supply of heroin to area History of nonfatal overdose is extremely common St. Petersburg: 75% ever overdosed, 60% >1 in the past year (Grau et al., under review) (vs % in US) 16 Russian cities: >80% witnessed an opioid overdose; 15% witnessed a fatal overdose (Sergeev, Karpets, Sarang, & Tikhonov, 2003) More Russian IDU die of overdose than AIDS each year 100, drug overdose deaths 23,037 from AIDS, 2007
3 Individual overdose risk factors Quality/quantity of opioid Concurrent use of other CNS depressants alcohol, benzodiazepines Injecting drugs while alone Comorbidities HCV, HIV Not tasting drug first May obscure role of other important aspects May obscure role of other important aspects contributing to overdose risk & prevention
4 Risk environment Social & structural factors influence production of risk HIV transmission i lack of sources for clean syringes (Platt et al., 2006; Rhodes et al., 2003) Antiretroviral adherence in FSU ARV for those drug free but ineffective drug treatment available (Wolfe, 2007) Micro vs. macro level factors (Kerr, Small, Moore, & Wood, 2007) Local/proximal vs. structural/distal Micro Norms Rules Values Neighborhood networks Macro Laws Policies Inequality
5 Rationale & Study Aim Overdose risk encompasses more than just individual actions & reactions Better understanding these factors will help determine feasibility & shape the specific contours of an effective public health intervention To describe factors at the micro & macro level characterizing the overdose risk environment in St. Petersburg & to assess prevention intervention feasibility
6 21 interviews Drug users (n=6) Dispensary narcologist (n=3) Ambulance staff (n=3) Interview guide Methods Toxicologists-poisoning i i i ward (n=3) Narcologists, inpatient (n=3) Police (n=3) Overdose prevention & response knowledge: opioid & non opioid Overdose experience (personal, witnessed), context & circumstances, typical responses Awareness of & openness to overdose intervention Thematic content analysis Survey of drug users (N=60) Overdose knowledge, perception of overdose problem in St. Petersburg History of overdose witnessed, experienced Clinical measures (Addiction severity index, SCL-90) Willingness to attend naloxone training
7 Themes Overdose & risk environment at micro/macro levels home & family conditions micro fear as a component of risk micro medical response to overdose macro inefficient emergency medical services (EMS) infrastructure macro inadequacy of drug users current interventions micro/macro
8 Home & Family Conditions Recent personal, witnessed overdoses associated with recent family conflict IDU younger, most living with family, spouses Family may influence use & overdose risk Inject in secret at home under physical/ time constraints My last overdose was a heroin overdose [it] happened at home. I d been in the toilet and I made an injection. My relatives felt that something was wrong, that I was in the toilet for too long, and then they opened the door and called an ambulance and began to slap my cheeks. User 3 Inject at other/ less safe locations to hide drug use from family Usually I inject at home or when my parents are not at home, but sometimes I have to inject on the street. User 2
9 Fear as a component of risk Fear of disease, deviance & thus drug users Legitimizes inaction to a witnessed overdose We have no instructions on how to respond [to] an overdose and I will not perform rescue breathing on a drug user- he can have AIDS! Police 2 Rationale for greater control over emergency response alter protocols to include police escort, opening possibility of harassment, arrest Gives impression that a call for help=call for police Fear of police by drug users engage in protective behaviors When we call the ambulance, we never tell them that it s an overdose, because we are afraid that they will call the police. I know some people who called an ambulance and told them it was an overdose and the police came. We never do that, that s why the police never come. When we call an ambulance, we say that something is wrong with the person s heart, unconscious, drunk on alcohol On the question about drug use, we say that we don t know, but think that he didn t take any. User 1
10 Emergency Infrastructure Emergency calls triaged Drug-involved: narcological ambulance,, otherwise non-specialized car responds 2 narcological of 190 ambulances in St.Petersburg Victim treated at hospital toxicology unit 40% of patient load are overdoses Saline solution IV, possible naloxone re-administration
11 Medical Response se to Overdose Misinformation about naloxone at professional level Contraindications, reservations about administering in hospital, side effects Missing first responder No training for police Compartmentalized, stratified structure; medical professionals perform, motivated to intervene We come only if there is a corpse. We have no instructions on what to do in cases of overdose. I don t know what to do to save a life. Maybe rescue breathing, but I will not do it. Police 1 Detoxification, treatment protocols 7-14 days; tranquilizers antipsychotics anticonvulsants 7-14 days; tranquilizers, antipsychotics, anticonvulsants cocktail; methadone & buprenorphine illegal
12 The last heroin overdose I witnessed was my brother s overdose. He had just come home from the hospital and he asked me to prepare a dose of heroin for him. The overdose happened on the stairs [outside]; it was only me and him. I did CPR on him. I was trained to do CPR - I m a professional driver - all drivers are trained to do that. And in the army they trained us, too. I called the ambulance, but it came too late. So, they called the police for the corpse. The police worked that t case as routine-they th just asked what [drug] and what dose he had injected. --User 4
13 Inefficient EMS Infrastructure Systemic delay, graft, & bureaucratization of care Poor reliability: 3 mins-1 hour response time Payment for services, not to call police The ambulance works effectively. They gave me an injection of medicine when they came and saved my life. But you should give them money so that they will not call the police - $12 is enough. User 5 Impression that ambulance will call police Impression of discriminatory treatment of drug-involved calls I think that the ambulance doesn t respond properly to an overdose call. They come too late. And I think that it s better not to tell them that it s an overdose, because they will come later or not come at all. User 6 Compartmentalization: overdoses not responded to by narcological acoogca ambulances a
14 Inadequacy of Drug Users Current Interventions Opioid overdose knowledge high but response knowledge variable Some effectual, ineffectual 41% doubted their ability to respond effectively, others overly confident As a rule, drug users know about and recognize the symptoms of overdose. But their actions in response to an overdose are not enough. All they do is slap the face and/or pour cold water [on the person]. Sometimes, they try to perform CPR but this usually leads to rib fractures. Ambulance 1 CPR, rescue breathing trainings limited Military, certain professions Community-based CPR training gprograms rare; no known programs in St. Petersburg
15 Overdose Prevention & Response Programs May include naloxone distribution, training of first responders, recognition of signs of opioid overdose Constitute effective structural interventions that alter overdose risk environment fundamentally Naloxone hydrochloride in Russia NOT on dangerous drugs list available by prescription in pharmacies $6 for 10 vial package
16 Window of Opportunity Surveyed & interviewed drug users willing to be trained in overdose prevention & response Police apathetic, supportive Medical professionals disapprove of interventions, especially naloxone distribution Only they can administer naloxone Endorses drug use Encourages more/careless drug use Underscored side effects, complications of naloxone Support overdose curriculum & training in continued medical education
17 Limitations Small sample size for interviews & survey This is the largest & only study of overdose in St. Petersburg Possible interviewer, i reporting bias Generalizability limited Local not regional, national scale Appropriateness of scale given geographic, cultural, contextual differences including in drug use
18 Conclusions & Recommendations Structural, social factors contribute to overdose risk Targeted structural interventions warranted to alter risk environment Family-based overdose, harm reduction interventions needed Community-based overdose prevention & naloxone distribution programs feasible Include drug users, families of drug users, other community members Consensus building with medical professionals Dispel myths about naloxone, side effects Provide evidence of naloxone distribution program effectiveness (Seal et al. 2001; Maxwell et al., 2006; Galea et al., 2006; Tobin et al., 2008; Green et al., 2008) Overcome resistance to training drug users CME for medical professionals; comprehensive training i on overdose risk, prevention & response for police Equip more ambulances with naloxone & staff trained in use
19 Acknowledgements e Thank you to the participants p & interviewees,, and to. Yale Center for Interdisciplinary Research on AIDS (CIRA) Alexandr Fialko, City Narcological Hospital, St. Petersburg Nikolay Blinnikov, Deputy Chief, International Division, Public Health Committee, St.Petersburg Mark Kinzly Dan Bigg Greg Scott Sharon Stancliff Monique Rucker This study was funded d by a NIH/Fogarty International ti Center as part of the International Clinical Operational and Health Services Research and Training Award (ICOHRTA; Grant #5U2RTW006893) and by a NIH/NIMH institutional training grant (Grant #5T32MH020031) for predoctoral fellowship (TCG) at CIRA
Take Home Naloxone Report on supply and use to reverse an overdose
Take Home Naloxone Report on supply and use to reverse an overdose 2012-2016 1 Contents 1. Introduction 2. How the Take Home Naloxone Programme works 3. How information is collected 4. Patients supplied
More information1/23/2015. Disclosure. Overview. A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care
A National Response to a Public Health Crisis Opioid Overdose and the Changing Spectrum of Care Michael W. Dailey, MD FACEP Chief, Division of Prehospital and Operational Medicine Associate Professor of
More informationTitle: Psychosocial and Contextual Correlates of Opioid Overdose Risk among Drug Users in St. Petersburg, Russia
Editorial Manager(tm) for Journal of Urban Health Manuscript Draft Manuscript Number: Title: Psychosocial and Contextual Correlates of Opioid Overdose Risk among Drug Users in St. Petersburg, Russia Article
More informationHarm Reduction 10/17/2018. Topics for Today. Working Definition of Harm Reduction
Harm Reduction Dennis Radloff Human Services Program Coordinator Substance Abuse Services Topics for Today Overview of harm reduction Sterile syringe access programs Preventing fatal opioid overdoses Working
More informationNaloxone: Preventing Opioid Overdose in the Community. Sharon Stancliff, MD Medical Director Harm Reduction Coalition
Naloxone: Preventing Opioid Overdose in the Community Sharon Stancliff, MD Medical Director Harm Reduction Coalition DISCLOSURES Sharon Stancliff MD has nothing to disclose LEARNING OBJECTIVES 1. Discuss
More informationOpioid Withdrawal, Opioid Substitution, and HIV Infection
Opioid Withdrawal, Opioid Substitution, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University New Haven, Connecticut Learning Objectives After attending
More informationOverdose. Everything you need to know. Includes free DVD!
Overdose Everything you need to know Includes free DVD! Please read this booklet. We guarantee you ll learn something new. When you ve read it, you ll know about overdose myths and: what to do if you
More informationOpioid Withdrawal, Opioid Substitution Treatment, and HIV Infection
Opioid Withdrawal, Opioid Substitution Treatment, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University Chief of Medicine Cornell Scott-Hill Health Center
More informationAPPENDIX: Key summary of six US-based naloxone distribution programs
Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States Traci C. Green, Robert Heimer, Lauretta
More informationBRIEFING ON WHY AND HOW TO ADDRESS OVERDOSE IN GLOBAL FUND PROPOSALS
BRIEFING ON WHY AND HOW TO ADDRESS OVERDOSE IN GLOBAL FUND PROPOSALS For people who inject heroin and other opioids, overdose is an urgent issue. The Global Fund to Fight AIDS, Tuberculosis and Malaria
More informationWelcome to the Opioid Overdose Prevention Project
Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize
More informationAnyone Can Become Addicted. Anyone.
Anyone Can Become Addicted. Anyone. PAStop.org Family Toolkit Seeking Drug Abuse Treatment: Know What to Ask Trying to identify the right treatment programs for a loved one can be a difficult process.
More informationHarm Reduction in a Clinical Encounter: Collecting substance use history in a non-judgmental manner
Testing and prevention of hepatitis C for people who inject drugs Do your patients understand the importance of hepatitis C testing and prevention? Taking an accurate and non-judgmental history of substance
More informationExpanding Medication-Assisted Therapies as HIV Treatment and Prevention in Ukraine
Expanding Medication-Assisted Therapies as HIV Treatment and Prevention in Ukraine Frederick L. Altice, M.D. M.A. Professor of Medicine & Public Health Yale University Disclosures and Funding Grants Merck,
More informationPresenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin
Public Health Nurses, Hepatitis C, Injection Drug Use and Heroin Sheila Guilfoyle Viral Hepatitis Prevention Coordinator Division of Public Health Wisconsin Department of Health Services Wisconsin Public
More informationData Driven Strategies
Data Driven Strategies Full Task Force Meeting September 16, 2014 Review the problems Snapshot of local data Task Force goals Risk factors Breakout groups Prevention Intervention Treatment Recovery Words
More informationScott Formica Social Science Research & Evaluation, Inc.
Developing Your MOAPC Strategic Plan: Selecting and Prioritizing Intervening Variables and Strategies May 12, 2015 9:30am to 11:00am Webinar Presentation Scott Formica Social Science Research & Evaluation,
More informationProject Narcan: BPD officers equipped with life-saving rescue drug
From: Kelli Williams, Chief Communications Officer City of Bartlesville Date: Oct. 24, 2017 For release: Immediate Project Narcan: BPD officers equipped with life-saving rescue drug By Kelli Williams City
More informationMethadone Diversion: Why it happens, what the illicit market looks like and the implications
Methadone Diversion: Why it happens, what the illicit market looks like and the implications Paul Duffy & Helen Baldwin Centre for Public Health Liverpool John Moores University Methadone provision and
More informationReducing opioid overdose mortality: role of communityadministered
Reducing opioid overdose mortality: role of communityadministered naloxone Vennus Ballen, MD, MPH; Lara Maldjian, MPH New York City Department of Health and Mental Hygiene Clinical Director s Network (CDN)
More informationClinical Education Initiative INTERACTIONS BETWEEN ARVS AND RECREATIONAL DRUGS. Speaker: Sharon Stancliff, MD
Clinical Education Initiative Support@ceitraining.org INTERACTIONS BETWEEN ARVS AND RECREATIONAL DRUGS Speaker: Sharon Stancliff, MD 12/6/2017 Diagnosing Acute HIV Infection in Your Clinical Setting [video
More informationOpioid Withdrawal, Opioid Substitution, and HIV Infection
Opioid Withdrawal, Opioid Substitution, and HIV Infection R. Douglas Bruce, MD, MA, MS Associate Clinical Professor of Medicine Yale University New Haven, Connecticut Learning Objectives After attending
More informationHarm Reduction 3/5/2019. Topics for Today. Working Definition of Harm Reduction. Scott Stokes Section Chief, Substance Abuse Services
Harm Reduction Scott Stokes Section Chief, Substance Abuse Services Topics for Today Overview of harm reduction Sterile syringe access programs Preventing fatal opioid overdoses Working Definition of Harm
More informationResearch on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation.
Research on opioid overdose and naloxone distribution in San Francisco: from epidemiology to intervention development to implementation. Alex H. Kral, PhD Director Behavioral and Urban Health Program RTI
More informationPREVENTING OPIATE OVERDOSES IN SCHOOLS. Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region
PREVENTING OPIATE OVERDOSES IN SCHOOLS Head 2 Toe 2017 April 20, 2017 Winona Stoltzfus BSN, MD, School Health Officer and Acting RHO SE Region WHY IS THIS EVEN A QUESTION FOR SCHOOLS? In 2014, 467,000
More informationOverdose Prevention, Recognition & Response Education Train-the-Trainer
Overdose Prevention, Recognition & Response Education Train-the-Trainer Bernie Lieving, MSW Overdose Prevention Education Coordinator Santa Fe Prevention Alliance & Office of Substance Abuse Prevention
More informationTaking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre
Taking away the chaos The health needs of people who inject drugs in public places in Glasgow city centre Plain-language summary The health needs of people who inject drugs in public places in Glasgow
More informationHARM REDUCTION & TREATMENT. Devin Reaves MSW
HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that
More informationGrampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum)
Grampian Naloxone Programme Pre-reading Materials (Adapted from materials supplied with the kind permission of the Scottish Drugs Forum) This presentation aims to refresh knowledge on the causes, risk
More informationBuilding Community Coalitions to Address the Opioid Crisis
Building Community Coalitions to Address the Opioid Crisis Understanding the Overdose Epidemic, Addiction, and Treatment Barry Zevin MD Medical Director Street Medicine and Shelter Health San Francisco
More informationReport on Overdose Education and Naloxone Distribution, Year 1
WA State Project to Prevent Prescription Drug/Opioid Overdose (WA-PDO) Report on Overdose Education and Naloxone Distribution, Year 1 Caleb Banta-Green, Susan Kingston November, 2017 PROJECT OVERVIEW The
More informationThe Opioid Epidemic: Overdose Data in NYC
The Opioid Epidemic: Overdose Data in NYC Sindhu Shamasunder, MPH Bureau of Alcohol and Drug Use Prevention, Care and Treatment NYC Department of Health and Mental Hygiene The burden of drug overdose Nationally,
More informationOpioids and Overdose 2017
Opioids and Overdose 2017 This presentation is an introduction to: 1. Opioids, overdose and naloxone 2. How you can help A partnership of: Opioids A class of drugs taken for pain relief or euphoria. Prescribed
More informationMainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders
Mainstreaming naloxone rescue kits from harm reduction programs to pharmacies, police and fire responders Alexander Y. Walley, MD, MSc Boston University School of Medicine ThINC Bergen 2015 Conference
More informationInjecting Drug Use and the Harm Reduction Model_Merritt_HPP-507. This paper explores the role that law enforcement and police actions can play as
This paper explores the role that law enforcement and police actions can play as structural deterrents to the conceptualization of drug addiction as a public health issue rather than as a criminal justice
More informationIntroduction. Preventing overdose
Third edition 02 Preventing overdose Introduction In the future, cigarette smoking and viral infections such as hepatitis C and HIV will cause the death of large numbers of people who inject illicit drugs.
More informationNaloxone HCI 4 mg/0.1. nostril. Repeat after 3 minutes if minimal or no
THE SOUTH CAROLINA BOARD OF MEDICAL EXAMINERS AND THE SOUTH CAROLINA BOARD OF PHARMACY S JOINT PROTOCOL TO INITIATE DISPENSING OF NALOXONE HCI WITHOUT A PRESCRIPTION This joint protocol authorizes any
More informationBuprenorphine treatment
South London and Maudsley NHS Foundation Trust Buprenorphine treatment Information for service users Page Buprenorphine treatment What is buprenorphine? Buprenorphine (trade name Subutex ) is an opioid
More informationAddiction Research Ethics and the Belmont Principles: Do Drug Users Have a Different Moral Voice?
Addiction Research Ethics and the Belmont Principles: Do Drug Users Have a Different Moral Voice? Celia B. Fisher Marie Ward Doty University Chair Director Center for Ethics Education Director HIV and
More informationThe Emergence of Gabapentin as a Drug of Abuse in a Cohort of Rural Appalachian Drug Users
The Emergence of Gabapentin as a Drug of Abuse in a Cohort of Rural Appalachian Drug Users Jennifer R. Havens, PhD, MPH Center on Drug and Alcohol Research Goals Describe the epidemiology of gabapentin
More informationDrug Use, Harm Reduction, and HIP
Drug Use, Harm Reduction, and HIP Strategies for Engaging PWIDs in HIV Prevention Services Presented by: Katie Burk, MPH Narelle Ellendon, RN Harm Reduction Coalition Founded in 1993 by needle exchange
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More informationGLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA. The critical need to scale up opioid substitution therapy
GLOBAL DRUG POLICY AND THE HIV/IDU EPIDEMIC IN EASTERN EUROPE AND CENTRAL ASIA The critical need to scale up opioid substitution therapy Craig McClure IAS Executive Director Outline of Presentation 1.
More informationProtecting the Good Samaritans who administer naloxone. Draft Discussion Paper V3 (August 2014)
Draft Discussion Paper V3 (August 2014) The purpose of this paper is to explore potential legal aspects of layperson (or peer) administration of naloxone under the Implementing Expanded Naloxone Availability
More informationWorkshop: A roadmap for overdose prevention policies: where do you fit?
Workshop: A roadmap for overdose prevention policies: where do you fit? Sharon Stancliff, MD, Harm Reduction Coalition Holly Catania, JD, International Doctors for Healthy Drug Policies June 12, 2013 Harm
More informationJust Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health
Just Out of Reach: Women Who Use Drugs, Stigma and Barriers to Care Erin Bortel and Lyla Hunt AIDS Institute Office of Drug User Health March 12, 2018 Envisioning a socially just system where all New Yorkers
More information9/17/2018 MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN
MISSION IMPOSSIBLE: IF YOU CHOOSE TO ACCEPT MISSION JOIN JUSTICE LEAGUE I M POSSIBLE HEPBURN 1 ADDICTION PREVENTION & TREATMENT SAVES LIVES According to the Food and Drug Administration s standards for
More informationTake Home Naloxone elearning Module Script
elearning Module Script Slide 1-3 Review the outline and the plan for the presentation. Slide 4 We do accept the cynicism of this poster. Slide 5 Read from the slide the definition of Harm Reduction Slide
More informationWhat is injection drug use?
What is injection drug use? Essential Standards 7.ATOD.1 Understand the health risks associated with alcohol, tobacco, and other drug use. Clarifying Objectives 7.ATOD.1.2 - Explain health risks resulting
More informationOregon ACEP Opioid Prescribing Guidelines. Why are we talking about this?
Oregon ACEP Opioid Prescribing Guidelines Hans Notenboom, M.D. FACEP Current OCEP President Why are we talking about this? Current opioid epidemic 33,000 deaths over half with Rx meds Since 1999 number
More informationOpportunities for Engaging Partners to Prevent Opioid Overdose-related Deaths
PREVENTION COLLABORATION IN ACTION Engaging the Right Partners Opportunities for Engaging Partners to Prevent Opioid Overdoserelated Deaths Preventing opioid overdose requires collaboration with a diverse
More informationEcstasy and Related Drugs Reporting System drug trends bulletin
Ecstasy and Related Drugs Reporting System JULY 2016 Stimulant and depressant overdose among a sample regular psychostimulant users in Australia, 2007-2015 Authors: Rachel Sutherland, Gavin Entwistle and
More informationBest Practices and Foundation Forum. Fred Wells Brason II
Best Practices and Foundation Forum Fred Wells Brason II fbrason@projectlazarus.org Wilkes County, NC Manual labor dominates employment options in this county of 69,000. Wilkes 4 Marvelous M s Moonshine
More informationFrequently Asked Questions about Supervised Injecting Facilities 24 July 2014
Frequently Asked Questions about Supervised Injecting Facilities 24 July 2014 1 Q: What are Supervised Injecting Facilities? A: These are places where people who inject drugs can go to inject in relative
More informationPerceived consequences of refusing to share injection equipment: A qualitative study
Perceived consequences of refusing to share injection equipment: A qualitative study Karla D. Wagner,* Stephen E. Lankenau, Lawrence A. Palinkas, Jean L. Richardson, Chih-Ping Chou, Jennifer B. Unger *Division
More informationPragmatic and Creative Responses to the Opioid Crisis in Connecticut
Focusing on Highly Vulnerable Populations Track Pragmatic and Creative Responses to the Opioid Crisis in Connecticut A special thanks to our presenting sponsor: Presenters: Shawn Lang Deputy Director AIDS
More informationTitle: Police Officer Attitudes towards Intranasal Naloxone Training
Title: Police Officer Attitudes towards Intranasal Naloxone Training Author names and affiliations: Bradley Ray, PhD ac Daniel O Donnell, MD b Kailyn Kahre, MD b a Indiana University Purdue University
More informationNALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE
NALOXONE LEARNING ABOUT NALOXONE COULD SAVE A LIFE WHAT IT IS WHAT IT IS NARCAN (naloxone HCl) Nasal Spray is the first and only FDA-approved nasal form of naloxone for the emergency treatment of a known
More informationHARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge
HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe
More informationSUBJECT: Opioid Overdose and Intranasal Naloxone Training for Law Enforcement: Train the Trainer Session: Queens County October 17, 2014
ANDREW M. CUOMO GOVERNOR STATE OF NEW YORK DIVISION OF CRIMINAL JUSTICE SERVICES Alfred E. Smith Office Building 80 South Swan Street Albany, New York 12210 http://criminaljustice.ny.gov MICHAEL C. GREEN
More informationCombating Opiate Addiction
Combating Opiate Addiction Patrick E Keefe Chief of Police July 2015 Statement of the Problem The recent heroin epidemic has spared no community or law enforcement agency. The wide availability of heroin
More informationMaking Naloxone available to potential overdose witnesses: evidence and policy opportunities
Making Naloxone available to potential overdose witnesses: evidence and policy opportunities Simon Lenton PhD MPsych(clin) www.ndri.curtin.edu.au Background Narcan reverses opioid effects &respiratory
More informationHow to Prevent an Opioid Overdose
How to Prevent an Opioid Overdose MEDICAL CARE PROVIDERS: Providers can help reduce the likelihood of an opioid overdose by identifying patients who are at increased risk of opioid-induced respiratory
More informationWorking with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.
Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,
More informationWashington State s Overdose Epidemic
Caleb Banta-Green PhD MPH MSW Senior Research Scientist- Alcohol and Drug Abuse Institute Affiliate Associate Professor- School of Public Health Affiliate Faculty- Harborview Injury Prevention & Research
More informationA guide to help you talk to your teen about alcohol, marijuana, and prescription pain medications. You, your teen, and Substance Use
A guide to help you talk to your teen about alcohol, marijuana, and prescription pain medications. You, your teen, and Substance Use What s inside Three Commonly Used Substances by Teens Reasons Why Teens
More informationCare in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities
Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program
More informationRash of fatal overdoses in Montreal could be linked to fentanyl
2 sur 10 2014-07-09 10:44 Rash of fatal overdoses in Montreal could be linked to fentanyl CBC News investigation reveals fentanyl was present in at least several cases of fatal overdose in Montreal Tracey
More informationPreventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction
Preventing overdose fatalities: The role of naloxone and of supervised injection facilities Sharon Stancliff, MD Medical Director Harm Reduction Coalition New York, NY Sleestan@gmail.com Strategies to
More informationCOMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, Objectives: Key Terms
COMBATING THE OPIATE CRISIS IN OHIO THROUGH COMPREHENSIVE RESPONSE 2018 HOUSING OHIO CONFERENCE APRIL 9 TH, 2018 2 Objectives: qreview names of different types of opioids qidentify the signs and symptoms
More informationPatient Information Leaflet
Page 25 Patient Information Leaflet PATIENT INFORMATION SUBOXONE (sub-ox-own) (buprenorphine HCl/naloxone HCl dihydrate, sublingual tablet) (C*) SUBUTEX (SUB-u-tex) (buprenorphine HCl, sublingual tablet)
More informationDPH programs related to opioid use disorder. Judith Martin, MD Medical Director of Substance Use Services SFDPH
DPH programs related to opioid use disorder Judith Martin, MD Medical Director of Substance Use Services SFDPH Opioid safety, SF timeline Opioid agonist treatment: methadone Seven clinics contract with
More informationBuprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008
Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality
More informationSierra Sacramento Valley EMS Agency
Sierra Sacramento Valley EMS Agency BLS IN NALOXONE ADMINISTRATION OPTIONAL SKILL (UPDATED 06/2017) Acknowledgement: Siskiyou County SO - source of some slide content In order for PSFA, EMR or EMT personnel
More informationEvaluations. Viewer Call-In. Guest Speakers. What s New in AIDS/HIV? Phone: Fax: Thank You to our Sponsors
What s New in AIDS/HIV? December 16, 2010 Guest Speakers Dr. Amneris Luque Director, AIDS Center at Strong Memorial Hospital Alma Candelas Director, Division of HIV Prevention, AIDS Institute Dan O Connell
More informationOHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS
OHIO S OPIOID DRUG OVERDOSE EPIDEMIC: CONTRIBUTING FACTORS AND ONGOING PREVENTION EFFORTS DEFINITIONS Opiate- originate from naturally-occurring elements found in the opium poppy plant. These drugs are
More informationNALOXONE CAN BE A LIFESAVER
NALOXONE 1 CAN BE A LIFESAVER Naloxone is a drug which can temporarily reverse the effects of opioid (heroin/methadone) overdose. In an overdose state, it can be a lifesaver 2 3 what to do IF SOMEONE HAS
More informationETHNO-EPIDEMIOLOGICAL APPROACHES TO UNDERSTANDING DRUG-RELATED RELATED HARM
ETHNO-EPIDEMIOLOGICAL APPROACHES TO UNDERSTANDING DRUG-RELATED RELATED HARM Combining Social Epidemiology and Ethnography to Study Health among Injection Drug Users in Vancouver Will Small 1,2 Evan Wood
More informationAddressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention
The Accountable Community for Health of King County Addressing the Opioid Crisis Workgroup: Treatment and Overdose Prevention May 7, 2018 1 Opiate Treatment & Overdose Prevention Project Goal Immediate:
More informationCommunity Pharmacy Distribution of Naloxone
Community Pharmacy Distribution of Naloxone College of Pharmacists of BC BC Centre for Disease Control Harm Reduction Program Sponsored in part by the BC Ministry of Health What is Naloxone? Naloxone is
More informationOpioid Harm Reduction
Opioid Harm Reduction Lucas G. Hill, PharmD Clinical Assistant Professor, The University of Texas at Austin College of Pharmacy Clinical Pharmacist, CommUnityCare FQHCs Director, Operation Naloxone Mark
More informationThe Opioid Epidemic: HHS Response
The Opioid Epidemic: HHS Response Christopher M. Jones, PharmD, MPH Acting Associate Deputy Assistant Secretary (Science and Data Policy) Office of the Assistant Secretary for Planning and Evaluation U.S.
More informationFACING ADDICTION OVER DINNER
FACING ADDICTION OVER DINNER The NATIONAL NIGHT of CONVERSATION November 17, 2016 The dinner table is one of the most important places in the house for improving the health of your family, but not only
More informationSubstance use and addictive disorders in Palliative care
Substance use and addictive disorders in Palliative care Dr. Maureen Allen BN, CCFP-EM(PC) Chronic Pain and Palliative Care Assistant Professor Dalhousie University September 22, 2017 No Disclosures SB:
More informationSafe Use, Storage, and Disposal of Opioid Drugs Safe Use, Storage, and Disposal of Opioid Drugs
Return to Web version Safe Use, Storage, and Disposal of Opioid Drugs Safe Use, Storage, and Disposal of Opioid Drugs What are opioids? Opioids (say: "oh-pee-oyds") are powerful pain relievers your doctor
More informationUsing Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release
Using Naloxone to Reduce the Number of Opioid Overdose Deaths Among Clackamas County Inmates Post-Release Apryl L. Herron, MPH Clackamas County Public Health Division Kristen Watson, CADC II, QMHA Clackamas
More informationHigh Impact Prevention for People Who Inject Drugs. June 30, 2015
High Impact Prevention for People Who Inject Drugs June 30, 2015 Webinar Agenda Introduction & Background o NASTAD Drug User Health: Challenges and Opportunities for Health Departments o Alessandra Ross,
More informationVictorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017
Victorian Parliamentary Inquiry into the Drugs, Poisons and Controlled Substances Amendment (Pilot Medically Supervised Injecting Centre) Bill 2017 19 April 2017 That the Government: VHA Recommendations
More informationPublic Health Approach to Addressing the Opioid Epidemic in NYC
Public Health Approach to Addressing the Opioid Epidemic in NYC Hillary Kunins, MD, MPH Assistant Commissioner Bureau of Alcohol and Drug Use Prevention, Care and Treatment New York City Department of
More informationNALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND
NALOXONE AND OVERDOSE PREVENTION EDUCATION PROGRAM OF RHODE ISLAND Law Enforcement and Public Safety!!!!!!! Ariel Engelman NOPE-RI Coordinator 1 Opioids and Overdose in Rhode Island 2 Opioids and Overdose
More informationwho use drugs in order to assist them in reducing harm while in the cycle of addiction
August 16, 2016 } Accepts that illicit drug use is part of our world, and chooses to minimize its harmful effects rather than ignore or condemn them } Calls for the provision of services to people who
More informationUnderstanding the Opiate Epidemic
Understanding the Opiate Epidemic An opiate is a narcotic analgesic that depresses the central nervous system. Natural opiates are derived from the poppy plant. Synthetic opiates are manufactured drugs
More informationPrevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies
Prevalence of HIV and risk behaviors among injecting drug users in Tallinn, Estonia in a series of cross-sectional studies Sigrid Vorobjov 1, Maris Salekešin 1, Katri Abel-Ollo 1, Anneli Uusküla 2, Don
More informationUnderstanding Medication in Addiction Treatment for Drug Court Participants
Understanding Medication in Addiction Treatment for Drug Court Participants Introduction This pocket guide is for drug court participants who may be prescribed or considering medication as a part of addiction
More informationResist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction
Resist the Opioid Pendulum: Understanding Opioids and Pain, and how they relate to Addiction Stefan G. Kertesz, MD, MSc Diplomate, American Board of Addiction Medicine Associate Professor, University of
More informationsome things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment
some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment This booklet was created to help you learn about opioids. You probably have lots
More informationStriking a Balance: a provider perspective.
Striking a Balance: a provider perspective kpfeifer@chcf.org Beth s story 38 years old, erratically employed Counseling doesn t help Chronic low back pain after car accident 8 Vicodin/day grew to 180 mg
More informationThe Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM
The Prescription Review Program and College Expectations Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM April 28, 2017 Disclosure Relationship with commercial interests: None Professional roles: Addictions
More informationFacing the Opioid Epidemic (FOE): Assessing and Responding to Prescription and Illicit Opioid Use and Misuse in 5 New England States
Facing the Opioid Epidemic (FOE): Assessing and Responding to Prescription and Illicit Opioid Use and Misuse in 5 New England States T h o m a s J. S t o p k a, P h D, M H S L e o B e l e t s k y, J D,
More information